
Karius develops clinical metagenomic tests that help clinicians identify pathogens causing serious infections.
kariusdx.comCrawled Oct 15, 2026
The page features clinician presentations on Karius testing solutions and their real-world applications in infectious disease detection.
Karius shares news about its advances in genomics and artificial intelligence.
The company’s team includes molecular biologists, software engineers, data scientists, clinicians, designers, and commercial experts.
The company’s team includes clinicians, molecular biologists, data scientists, software engineers, and commercial experts.
Karius uses metagenomics and AI for infectious disease diagnostics at hospitals and transplant centers.
Karius participates in virtual and in-person conferences and events to present its latest clinical data.
Karius is a CLIA-certified, CAP-accredited lab that offers infectious disease testing in the US and provides copies of its licenses and certifications.
Karius provides a contact form, and a member of its team will respond to submissions.
The company provides infectious disease diagnostics powered by microbial DNA and NGS.
Karius, Inc.’s notice describes how it collects, uses, and discloses information, including personal health information, through its website, online platforms, and mobile applications.
Karius, Inc. maintains kariusdx.com, including the Karius Assistant chatbot, as a service for prospective and current customers, patients, their families, and the internet community. The website provides information about Karius, its clinical tests, services, and scientific research.
Karius launched Karius Focus | BAL, a microbial cell-free DNA test that uses bronchoalveolar lavage samples to identify pathogens causing lung infections. The test is designed especially for use in immunocompromised patients.
Apr 2025 · Inside Precision MedicineNews article
Karius secured a BARDA DRIVe contract valued above $600,000. The contract supports extending pathogen detection from DNA to RNA across human samples.
Aug 2024 · Clinical Lab ProductsNews article
GitHubRepository owner
The FDA grants the Karius Test Breakthrough Device Designation to assist in diagnosing infectious diseases. The designation cites diagnostic-yield data from the PICKUP study.
May 2024 · ContagionLiveNews article